CompletedNCT03045341
Behavioral Weight Support and Medication for Binge-Eating Disorder
About this title
Read the official source — NCT03045341Medication studyAges 18–70United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: February 27, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 136
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug, OTHER
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT03045341
- Official title
Show the full official title
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including NB medication (Naltrexone Bupropion combination).
Who was this study for?
Listed age limits: 18 years to 70 years.
